Institutional Ownership
Eli Lilly & Co
CUSIP 532457108COMLLYQ1 2026
Latest EPS (Diluted)
$8.26
Q1 2026 · Mar 31, 2026
Latest Revenue
$19.80B
Reported quarter
Latest Net Income
$7.40B
Reported quarter
Quarters on Record
12
From SEC XBRL filings
Quarterly Earnings
EPS, revenue & net income · SEC XBRL (10-Q / 10-K)
| Period | Quarter | EPS (Basic) | EPS (Diluted) | Revenue | Net Income | Form |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Q1 2026 | $8.27 | $8.26 | $19.80B | $7.40B | 10-Q |
| Sep 30, 2025 | Q3 2025 | $6.22 | $6.21 | $17.60B | $5.58B | 10-Q |
| Jun 30, 2025 | Q2 2025 | $6.30 | $6.29 | $15.56B | $5.66B | 10-Q |
| Mar 31, 2025 | Q1 2025 | $3.07 | $3.06 | $12.73B | $2.76B | 10-Q |
| Sep 30, 2024 | Q3 2024 | $1.08 | $1.07 | $11.44B | $970.30M | 10-Q |
| Jun 30, 2024 | Q2 2024 | $3.29 | $3.28 | $11.30B | $2.97B | 10-Q |
| Mar 31, 2024 | Q1 2024 | $2.49 | $2.48 | $8.77B | $2.24B | 10-Q |
| Sep 30, 2023 | Q3 2023 | $-0.06 | $-0.06 | $9.50B | -$57.40M | 10-Q |
| Jun 30, 2023 | Q2 2023 | $1.96 | $1.95 | $8.31B | $1.76B | 10-Q |
| Mar 31, 2023 | Q1 2023 | $1.49 | $1.49 | $6.96B | $1.34B | 10-Q |
| Sep 30, 2022 | Q3 2022 | $1.61 | $1.61 | $6.94B | $1.45B | 10-Q |
| Jun 30, 2022 | Q2 2022 | $1.06 | $1.05 | $6.49B | $952.50M | 10-Q |